- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Aegerion Pharmaceuticals Inc+ Add to Watchlist
AEGR:US35.6500 USD 5.0300 16.43%
As of 17:20:00 ET on 07/30/2014.
Company Profile for Aegerion Pharmaceuticals Inc (AEGR)
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches small-molecule therapeutics for cardiovascular and metabolic disease. Aegerion's product candidates limit secretion of cholesterol and triglycerides.
Aegerion Pharmaceuticals Inc
Key Executives for Aegerion Pharmaceuticals Inc (AEGR)
|Marc D BeerChief Executive Officer||Mark J FitzpatrickChief Financial Officer|
|Mark SumerayChief Medical Officer||Martha J CarterSenior VP/Chief Regulatory|
|Craig FraserPresident: US Commercial||Anne Marie CookSenior VP/Secretary/Gen Cnsl|